Zinc

Identification
Generic Name
Zinc
Brand Name

 

Indication

Condition Contra-Indication
Our Records are Incomplete for Condition-Contra Indications

 
Other Contra-Indication
Our Records are Incomplete for Other Contra-Indications

Contra-Indication
Our Records are Incomplete for Drug Contra-Indications

 
Class Contra-Indication
Our Records are Incomplete for Drug Class Contra-Indications

We have incomplete side-effect data.

Side Effects
Efficacy of Zinc as an Alternative Medicine According to GRADE* Ranking: 

Age Related Macular Regeneration [1, 2]:

Recommendation: Weakly in favor (Early studies show that zinc may be able to slow the progression of AMD. More studies are needed)

Grade of Evidence: Low level of evidence


Herpes Simplex Virus Infections [3, 4, 5]:

Recommendation: Weakly in favor (Zinc may help prolong remissions when applied topically. More studies are needed)

Grade of Evidence: Low level of evidence


Extrapulmonary Tuberculosis:

Recommendation: No recommendation (There is insufficient evidence to support claims that zinc is able to help treat extrapulmonary tuberculosis. More studies needed)

Grade of Evidence: Very low level of evidence


Community Acquired Pneumonia [6, 7, 8, 9, 10]:

Recommendation: No recommendation (Current studies have yielded mixed results on the level of efficacy of zinc as a treatment for pneumonia. More studies are needed)

Grade of Evidence: Low level of evidence


Alzheimer's Disease [11, 12, 13, 14, 15]:

Recommendation: No recommendation (Although Zinc has been found to be deficient in patients with AD and a few limited studies have found slight benefits in taking Zinc, there is insufficient evidence to validate a recommendation for taking Zinc for the treatment of AD. Further research is needed) 

Grade of Evidence: Low level of evidence


Gram Negative Bacilli Pneumonia [16, 17, 18]:

Recommendation: No recommendation (Studies on the efficacy of zinc for treating pneumonia have yielded mixed conclusions. More studies are needed)

Grade of Evidence: Low level of evidence


Herpes Simplex Virus Infections [3, 4, 5]:

Recommendation: Weakly in favor (Zinc may help prolong remissions when applied topically. More studies are needed)

Grade of Evidence: Low level of evidence


Erectile Dysfunction [19, 20, 21]:

Recommendation: Weakly in favor (Studies show that zinc may be able to help treat those with erectile dysfunction)

Grade of Evidence: Low level of evidence


* www.gradeworkinggroup.org 

References: 

1. http://www.ncbi.nlm.nih.gov/pubmed/11594942

2. http://knowledgeofhealth.com/special-report-antioxidants-zinc-for-macular-degeneration/

3. https://umm.edu/health/medical/altmed/condition/herpes-simplex-virus

4. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3730471/

5. http://pennstatehershey.adam.com/content.aspx?productId=107&pid=33&gid=000079

6. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2323679/

7. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2276784/

8. http://www.healthnet.org.np/ebook/imci/cough/bhuttaza.pdf

9. http://www.researchgate.net/profile/W_Abdullah_Brooks/publication/7594531_Effect_of_weekly_zinc_supplements_on_incidence_of_pneumonia_and_diarrhoea_in_children_younger_than_2_years_in_an_urban_low-income_population_in_Bangladesh_randomised_controlled_trial/links/54336f3a0cf20c6211be4bb7.pdf

10. http://www.ijponline.net/content/38/1/36

11. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3810325/

12. http://www.ncbi.nlm.nih.gov/pubmed/25835420

13. http://www.ncbi.nlm.nih.gov/pubmed/21949909

14. http://www.sciencedirect.com/science/article/pii/S0092867410009384

15. http://www.sciencedirect.com/science/article/pii/S0896627301003178

16. http://www.ncbi.nlm.nih.gov/pubmed/17921398

17. http://ajcn.nutrition.org/content/83/5/1089

18. http://ajcn.nutrition.org/content/85/1/242

19. http://www.healthline.com/health/erectile-dysfunction/zinc

20. http://drlwilson.com/Articles/SEXUAL%20PROBLEMS.htm

21. http://www.nature.com/ijir/journal/v16/n1s/full/3901205a.html



Public Discussion

No discussions exist for this vitamin yet. You can be the first to create one!

GT:0.034